Literature DB >> 31646435

Homeobox B8 Targets Sterile Alpha Motif Domain-Containing Protein 9 and Drives Glioma Progression.

Wenping Ma1,2,3, Hongze Jin4, Wenjie Liu5, Xiaojuan Li6, Xingang Zhou7, Xinwu Guo8, Runfa Tian2, Qi Cui1, Junjie Luo1, Yueying Jiao1, Youtao Yu9, Haifeng Yang10, Hongshan Zhao11.   

Abstract

Gliomas are the most commonly occurring tumors of the central nervous system. Glioblastoma multiforme (GBM) is the most malignant and aggressive brain cancer in adults. Further understanding of the mechanisms underlying the aggressive nature of GBM is urgently needed. Here we identified homeobox B8 (HOXB8), a member of the homeobox family, as a crucial contributor to the aggressiveness of GBM. Data mining of publicly accessible RNA sequence datasets and our patient cohorts confirmed a higher expression of HOXB8 in the tumor tissue of GBM patients, and a strong positive correlation between the expression level and pathological grading of tumors and a negative correlation between the expression level and the overall survival rate. We next showed that HOXB8 promotes the proliferation and migration of glioblastoma cells and is crucial for the activation of the PI3K/AKT pathway and expression of epithelial-mesenchymal transition-related genes, possibly through direct binding to the promoter of SAMD9 (Sterile Alpha Motif Domain-Containing Protein 9) and activating its transcription. Collectively, we identified HOXB8 as a critical contributor to the aggressiveness of GBM, which provides insights into a potential therapeutic target for GBM and opens new avenues for improving its treatment outcome.

Entities:  

Keywords:  Aggressiveness; Glioma; HOXB8; SAMD9; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31646435      PMCID: PMC7142204          DOI: 10.1007/s12264-019-00436-y

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  34 in total

Review 1.  Treatment options for recurrent high-grade gliomas.

Authors:  Harjus S Birk; Seunggu J Han; Nicholas A Butowski
Journal:  CNS Oncol       Date:  2016-12-21

2.  Mosaic analysis with double markers reveals tumor cell of origin in glioma.

Authors:  Chong Liu; Jonathan C Sage; Michael R Miller; Roel G W Verhaak; Simon Hippenmeyer; Hannes Vogel; Oded Foreman; Roderick T Bronson; Akiko Nishiyama; Liqun Luo; Hui Zong
Journal:  Cell       Date:  2011-07-07       Impact factor: 41.582

3.  CSF-Based Analysis for Identification of Potential Serum Biomarkers of Neural Tube Defects.

Authors:  Xinyu Yan; Lixin Mai; Changchun Lin; Wenji He; Gengsheng Yin; Jiakang Yu; Lian Huang; Sanqiang Pan
Journal:  Neurosci Bull       Date:  2017-07-10       Impact factor: 5.203

4.  Immunohistochemical comparative analysis of GFAP, MAP - 2, NOGO - A, OLIG - 2 and WT - 1 expression in WHO 2016 classified neuroepithelial tumours and their prognostic value.

Authors:  David Emanuel Schwab; Guilherme Lepski; Christian Borchers; Katrin Trautmann; Frank Paulsen; Jens Schittenhelm
Journal:  Pathol Res Pract       Date:  2017-12-14       Impact factor: 3.250

5.  Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer.

Authors:  Qing Ma; Tao Yu; Yao-Yao Ren; Ting Gong; Dian-Sheng Zhong
Journal:  Biochem Biophys Res Commun       Date:  2014-10-17       Impact factor: 3.575

6.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.

Authors:  Dov Hershkovitz; Yonit Gross; Sagi Nahum; Shiran Yehezkel; Ofer Sarig; Jouni Uitto; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

7.  Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression.

Authors:  B Z Vider; A Zimber; D Hirsch; D Estlein; E Chastre; S Prevot; C Gespach; A Yaniv; A Gazit
Journal:  Biochem Biophys Res Commun       Date:  1997-03-27       Impact factor: 3.575

Review 8.  Histologic classification of gliomas.

Authors:  Arie Perry; Pieter Wesseling
Journal:  Handb Clin Neurol       Date:  2016

9.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Authors:  Michele Ceccarelli; Floris P Barthel; Tathiane M Malta; Thais S Sabedot; Sofie R Salama; Bradley A Murray; Olena Morozova; Yulia Newton; Amie Radenbaugh; Stefano M Pagnotta; Samreen Anjum; Jiguang Wang; Ganiraju Manyam; Pietro Zoppoli; Shiyun Ling; Arjun A Rao; Mia Grifford; Andrew D Cherniack; Hailei Zhang; Laila Poisson; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli; Arvind Rao; Tom Mikkelsen; Ching C Lau; W K Alfred Yung; Raul Rabadan; Jason Huse; Daniel J Brat; Norman L Lehman; Jill S Barnholtz-Sloan; Siyuan Zheng; Kenneth Hess; Ganesh Rao; Matthew Meyerson; Rameen Beroukhim; Lee Cooper; Rehan Akbani; Margaret Wrensch; David Haussler; Kenneth D Aldape; Peter W Laird; David H Gutmann; Houtan Noushmehr; Antonio Iavarone; Roel G W Verhaak
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

10.  Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.

Authors:  K Sugimachi; T Matsumura; H Hirata; R Uchi; M Ueda; H Ueo; Y Shinden; T Iguchi; H Eguchi; K Shirabe; T Ochiya; Y Maehara; K Mimori
Journal:  Br J Cancer       Date:  2015-01-13       Impact factor: 7.640

View more
  7 in total

1.  Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy.

Authors:  Qiang Dong; Degui Wang; Lanlan Li; Jie Wang; Qiao Li; Lei Duan; Hang Yin; Xiaoqing Wang; Yang Liu; Guoqiang Yuan; Yawen Pan
Journal:  Mol Neurobiol       Date:  2022-01-04       Impact factor: 5.590

2.  A Specific Peptide Vaccine Against IDH1(R132H) Glioma.

Authors:  Yuqian Huang; Yongjie Wang; Zhihui Huang
Journal:  Neurosci Bull       Date:  2021-11-05       Impact factor: 5.203

3.  SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma.

Authors:  Wenping Ma; Kenan Zhang; Zhaoshi Bao; Tao Jiang; Ying Zhang
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

4.  Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma.

Authors:  Quanwei Zhou; Xuejun Yan; Hecheng Zhu; Zhaoqi Xin; Jin Zhao; Wenyue Shen; Wen Yin; Youwei Guo; Hongjuan Xu; Ming Zhao; Weidong Liu; Xingjun Jiang; Caiping Ren
Journal:  Theranostics       Date:  2021-10-03       Impact factor: 11.556

Review 5.  Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.

Authors:  Richard Morgan; Keith Hunter; Hardev S Pandha
Journal:  Int J Cancer       Date:  2022-02-15       Impact factor: 7.316

Review 6.  RSF1 in cancer: interactions and functions.

Authors:  Guiyang Cai; Qing Yang; Wei Sun
Journal:  Cancer Cell Int       Date:  2021-06-19       Impact factor: 5.722

7.  LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.

Authors:  Wenping Ma; Zhaoshi Bao; Zenghui Qian; Kenan Zhang; Wenhua Fan; Jianbao Xu; Changyuan Ren; Ying Zhang; Tao Jiang
Journal:  CNS Neurosci Ther       Date:  2022-03-26       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.